Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)

This study has been terminated.
(European reports of liver toxicity from kava meant that the study had to stop)
Sponsor:
Information provided by (Responsible Party):
National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:
NCT00083980
First received: June 4, 2004
Last updated: October 18, 2012
Last verified: August 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2004
  Primary Completion Date: June 2004 (Final data collection date for primary outcome measure)